Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Juraj Prejac

35167

Juraj

Prejac

dr. sc.

nije evidentirano
Naziv Akcije
Prejac, Juraj; Omrčen, Tomislav; Radić, Jasna; Vrdoljak, Eduard; Frobe, Ana; Pleština, Stjepko Predicting Trifluridine/Tipiracil Treatment in Refractory Metastatic Colorectal Cancer Patients: A Multicenter Exploratory Analysis // Oncology, (2023), doi: 10.1159/000533567
Librenjak, Nikša ; Prejac, Juraj ; Kekez, Domina ; Goršić, Irma ; Pleština, Stjepko The effect of duration of induction therapy on survival in patients receiving maintenance therapy in the first line for metastatic colorectal cancer: A single-center retrospective analysis // Annals of oncology / André, F. (ur.). 2022. str. S330-S330 doi: 10.1016/j.annonc.2022.04.320
Prejac, Juraj ; Omrčen, Tomislav ; Radić, Jasna ; Vrdoljak, Eduard ; Fröbe, Ana ; Pleština, Stjepko A multicenter exploratory analysis of the possible predictive factors for trifluridine/tipiracil in refractory metastatic colorectal cancer // Annals of oncology / André, F. (ur.). 2022. str. S316-S316 doi: 10.1016/j.annonc.2022.04.276
Prejac, Juraj ; Tomek Hamzić, Dora ; Librenjak, Nikša ; Goršić, Irma ; Kekez, Domina MD ; Pleština, Stjepko The effectiveness of nab-paclitaxel plus gemcitabine and gemcitabine monotherapy in first- line metastatic pancreatic cancer treatment: A real-world evidence // Medicine, 101 (2022), 39; e30566, 7. doi: 10.1097/MD.0000000000030566
Prejac, Juraj ; Kekez, Domina ; Belev, Borislav ; Prejac, Marija ; Pleština, Stjepko Frequency of Body Weight Loss is an Independent Prognostic Factor of First-Line Treatment Outcomes in Metastatic Colorectal Cancer // Nutrition and cancer, 74 (2022), 2; 520-526. doi: 10.1080/01635581.2021.1900300
Prejac Juraj, Omrčen Tomislav, Radić Jasna, Froebe Ana, Vrdoljak Eduard, Pleština Stjepko Possible predictive factors for the effectiveness of trifluridine/tipiracil in refractory metastatic colorectal cancer. A multicenter exploratory analysis // Libri oncologici : Croatian journal of oncology. 2021. str. 117-118
Prejac, Juraj ; Dedić Plavetić, Natalija ; Gotovac Jerčić, Kristina ; Borovečki, Fran A first report of a rare TP53 variant associated with Li-Fraumeni syndrome manifesting as invasive breast cancer and malignant solitary fibrous tumor // World journal of surgical oncology, 19 (2021), 1; 254, 6. doi: 10.1186/s12957-021-02370-8
Momčilović, Berislav ; Prejac, Juraj ; Mimica, Ninoslav Assessing human molybdenum nutritional status by analyzing frequency distribution properties in the hair and whole blood with a median derivatives bioassay // Current developments in nutrition, 4 (2020), Suppl 2; 1455, 1. doi: 10.1093/cdn/nzaa061_083
Prejac, Juraj ; Kekez, Domina ; Pleština, Stjepko Treatment outcomes of trifluridine/tipiracil therapy in refractory metastatic colorectal cancer: A single-centre observational study // Annals of oncology. 2020. str. S154-S154 doi: 10.1016/j.annonc.2020.04.277
Prejac, Juraj ; Kekez, Domina ; Belev, Borislav ; Kocić, Lidija ; Bulimbašić, Stela ; Pleština, Stjepko Leukocytoclastic vasculitis associated with sorafenib treatment for hepatocellular carcinoma // Anti-cancer drugs, 31 (2020), 1; 76-79. doi: 10.1097/cad.0000000000000840
nije evidentirano
nije evidentirano